Day: December 22, 2022

Figure 1 Hole GBDD003 Home Reef intersection between 74.45m – 79.2m (red outline). VG is visual goldFigure 2 Visible intersection of GBDD003 at 75.5m. Gold hosted in Intense siderite/white mica fracture fill vein (photo 1)Figure 3 Intense silica replacement of host rock with stringer style arsenopyrite/pyrite and course euhedral arsenopyrite mineralisation that can carry gold mineralization (photo 2).Figure 4 Current drill section at Golden Bar Prospect.Figure 5 Plan view of Golden Bar Prospect, LiDAR (blue) surface over 1908 mine plan (Kenny, 1966).Figure 6 Golden Bar long sections of Shaws and Home Reef workings. Looking north-east.Figure 7 Composite images of the Home and Shaw’s Reef. Note sulphide reflections in silica replaced faults – conduit for goldFigure 8 Prospect plan of Rose, Thistle and Shamrock...

Korea Fair Trade Commission (KFTC) – GTT appeals the Seoul High Court’s decision dated December 1, 2022 Paris – December 22, 2022. GTT announced that it has appealed the Seoul High Court’s decision of December 1, 2022 before the Supreme Court of Korea. As a reminder, this decision partially granted GTT’s appeal against the Korea Fair Trade Commission’s corrective order by revoking the €9.5 million administrative fine paid by GTT, but confirmed the Company’s obligation to separate the technology license agreement from the technical assistance if requested by the Korean shipyards. GTT’s appeal is related to the obligation to separate the technology license and the technical assistance. It will be accompanied by a request for suspension of the decision. On the other hand, the KFTC has appealed against the...

InnerScope Launched its HearingAssist Brand of Over-the-Counter Rechargeable Hearing Aids on CVS.com and in Selected CVS Stores in Massachusetts and Rhode Island ROSEVILLE, CA, Dec. 22, 2022 (GLOBE NEWSWIRE) — InnerScope Hearing Technologies Inc. (OTC: INND) (“InnerScope”), an emerging and disruptive leader in the Over-the-Counter (OTC) Hearing Aid space today announced its subsidiary HearingAssist, America’s #1 Affordable OTC Hearing Aid Brand had launched its FDA-Registered Over-the-Counter (“OTC”) Rechargeable Hearing Aids (“HearingAssist Rechargeable OTC Hearing Aids”) on CVS.com. In addition, HearingAssist OTC Hearing Aids was also launched in eight selected CVS pharmacy locations in Massachusetts and Rhode Island.   CVS Pharmacy locations that have in-store stock of HearingAssist...

EXOR N.V. (AMS: EXO) (“Exor”) today starts the process of the implementation of the Board resolution to cancel 7,007,464 ordinary shares or just under 3% of Exor’s ordinary issued share capital. These ordinary shares have been acquired as part of the share buyback program which started on 14 November 2018 and completed on 6 November 2020 (for a total of 5,483,361 ordinary shares) and the first tranche of the share buyback program which started on 8 March 2022 and completed on 20 June 2022 (for a total of 1,524,103 ordinary shares). The cancellation of these ordinary shares, which is in line with the intention announced at the launch of the buyback program, will be conducted in the framework of the resolution adopted by the Annual General Meeting of Shareholders held on 24 May 2022. Pursuant to the relevant statutory provisions and...

ING Group 2022 SREP process completed ING Group has been notified of the European Central Bank (ECB) decision on the 2022 Supervisory Review and Evaluation Process (SREP), based on which it has taken a decision on ING’s prudential requirements, including capital requirements for 2023. ING Group’s fully loaded CET1 requirement is 10.96%, reflecting a countercyclical capital buffer of 47bps (fully loaded per Q3 2023). The current countercyclical capital buffer for ING Group is 4bps. In terms of Pillar 2 additional own funds requirement for ING Group, the outcome remained unchanged at 175bps, applicable per 1 January 2023. As of 30 September 2022, ING’s fully-loaded CET1 ratio was 14.7%, well in excess of the regulatory requirements. Further information on ING’s capital requirements can be found in the ING Group Credit Update presentation...

Silesia 2 wind farm, owned by Ignitis renewables, a subsidiary of Ignitis Group, has secured a Contract for Difference incentive tariff for a portion of the wind farm’s annual electricity output in the Polish auction system for renewables. Indexed yearly for an inflation, 274.99 PLN/MWh (59 EUR/MWh) tariff has been secured for 35% of the total planned electricity production during a 15-year tariff period and will significantly reduce electricity price volatility risk. The remaning electricity volume of the wind farm will be either realized on the market or contracted via long term energy sale agreements. A 137 MW installed capacity Silesia 2 wind farm is currently under construction with an estimated COD in 2024. The closing of Silesia 2 acquisition transaction took place in November 2022 – as previously announced (link) – and is a significant...

Silesia 2 wind farm, owned by Ignitis renewables, a subsidiary of Ignitis Group, has secured a Contract for Difference incentive tariff for a portion of the wind farm’s annual electricity output in the Polish auction system for renewables. Indexed yearly for an inflation, 274.99 PLN/MWh (59 EUR/MWh) tariff has been secured for 35% of the total planned electricity production during a 15-year tariff period and will significantly reduce electricity price volatility risk. The remaning electricity volume of the wind farm will be either realized on the market or contracted via long term energy sale agreements. A 137 MW installed capacity Silesia 2 wind farm is currently under construction with an estimated COD in 2024. The closing of Silesia 2 acquisition transaction took place in November 2022 – as previously announced (link) – and is a significant...

PRESS RELEASE AB SCIENCE ANNOUNCES THE DRAWDOWN OF THE FIRST TRANCHE OF 6 MILLION EUROS UNDER ITS FINANCING AGREEMENT WITH THE EUROPEAN INVESTMENT BANK Paris, December 22, 2022, 6pm CET AB Science SA (Euronext – FR0010557264 – AB) announced today that it has received payment of €6.0 million as the first tranche of a €15 million loan from the European Investment Bank (EIB). As previously announced [1], the agreement signed with the EIB provides a financing in two tranches of EUR 6.0 million and a third tranche of EUR 3.0 million, each subject to the fulfillment of certain conditions precedent, which have been satisfied for the first two tranches. Each tranche is accompanied by the issue of warrants, the number of which is calculated in relation to a reference price of 14 euros according to the following formula : Number of warrants...

Disclosure of Share Capital and Voting Rights Outstanding as of November 30, 2022 (Pursuant to Article L.233-8 II of the French Commercial Code and articles 221-1 and 223-16 of the General Regulations of the Autorité des Marchés Financiers) Charenton-le-Pont, France (December 22, 2022 – 6:00 pm) – As of November 30, 2022, shares and voting rights outstanding of EssilorLuxottica, the global leader in the design, manufacture and distribution of ophthalmic lenses, frames and sunglasses, breaks down as indicated below.  November 30, 2022Shares outstanding           447,452,7641Number of real voting rights (excluding treasury shares) 444,659,008Theoretical number of voting rights (including treasury shares) 447,452,764It is to be noted that voting rights are capped at 31%, applicable to any shareholder, in accordance with...